Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H23N2S2.I |
| Molecular Weight | 518.477 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 3 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[I-].CCN1C(SC2=C1C=CC=C2)=CC=CC=CC3=[N+](CC)C4=C(S3)C=CC=C4
InChI
InChIKey=MNQDKWZEUULFPX-UHFFFAOYSA-M
InChI=1S/C23H23N2S2.HI/c1-3-24-18-12-8-10-14-20(18)26-22(24)16-6-5-7-17-23-25(4-2)19-13-9-11-15-21(19)27-23;/h5-17H,3-4H2,1-2H3;1H/q+1;/p-1
| Molecular Formula | C23H23N2S2 |
| Molecular Weight | 391.572 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 3 |
| Optical Activity | NONE |
| Molecular Formula | HI |
| Molecular Weight | 127.91241 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Dithiazanine, 3-ethyl-2-[5-(3-ethyl-2-benzothiazolinylidene)-l, 3-
pentadienyl] benzothiazolium iodide, is an old effective broad-spectrum human anthelmintic. In proper dosage, this polyvermicide is therapeutic for trichuriasis, strongyloidiasis, ascariasis, and enterobiasis. The drug also has significant anthelmintic
activity against human hookworm, Necator americanus.
It fulfills a need for an effective therapeutic
for trichuriasis and strongyloidiasis. Dithiazanine is
useful for the treatment of patients with either
single or multiple intestinal helminth infections. It
is effective for mass therapy for trichuriasis. Nowdays Dithiazanine is used only as a veterinary anthelmintic for dogs. It has being proved to be a highly toxic chemical, with a lethal dose for humans of about 4–16 mg/kg by oral ingestion.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Trichuris Trichiura |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | Dithiazanine iodide Approved UseUse for treating dogs for large
roundworms, hookworms, whipworms,
and strongyloides |
|||
| Curative | Delvex Approved UseHelminth (worm) infections |
Doses
| Dose | Population | Adverse events |
|---|---|---|
300 mg 3 times / day multiple, oral Highest studied dose Dose: 300 mg, 3 times / day Route: oral Route: multiple Dose: 300 mg, 3 times / day Sources: |
unhealthy |
Disc. AE: Nausea... AEs leading to discontinuation/dose reduction: Nausea (1.37%) Sources: |
200 mg 3 times / day multiple, oral Studied dose Dose: 200 mg, 3 times / day Route: oral Route: multiple Dose: 200 mg, 3 times / day Sources: |
unhealthy |
Disc. AE: Vomiting... AEs leading to discontinuation/dose reduction: Vomiting (severe, 11.43%) Sources: |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Nausea | 1.37% Disc. AE |
300 mg 3 times / day multiple, oral Highest studied dose Dose: 300 mg, 3 times / day Route: oral Route: multiple Dose: 300 mg, 3 times / day Sources: |
unhealthy |
| Vomiting | severe, 11.43% Disc. AE |
200 mg 3 times / day multiple, oral Studied dose Dose: 200 mg, 3 times / day Route: oral Route: multiple Dose: 200 mg, 3 times / day Sources: |
unhealthy |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. | 2013-07-16 |
|
| The effect of non-immune stresses on the development of Strongyloides ratti. | 2005-09 |
|
| [In Vitro Activities Of Various Drugs Against Adult Worms Of Clonorchis Sinensis] | 1980-12 |
|
| Dithiazanine, an effective broad-spectrum anthelmintic; results of therapy of trichuriasis, strongyloidiasis, enterobiasis, ascariasis, and hookworm infection. | 1957-12-21 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13480859
Trichuriasis in 164 patients was treated with doses of 200 mg. thrice daily; this dosage, continued for five days, cured 97% of the patients. Ascariasis was treated in 42 persons with up to 600 mg. daily in divided doses. There was a 97% reduction in the egg-count of these patients, and 28 of them showed complete elimination of the infection. Strongyloidiasis was eliminated in 16 out of a group of 18 patients treated for 5 to 21 days. Enterobiasis was treated in 35 boys under conditions showing that 100 mg. of dithiazanine thrice daily for five days sufficed for cure in all cases.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12902729
Moderate in vitro activity against adult worms of Clororchis sinensis was observed in the concentrations of 1.0 and 0.1 ug/ml of gentian dithiazanine.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:31:47 GMT 2025
by
admin
on
Wed Apr 02 08:31:47 GMT 2025
|
| Record UNII |
8OEC3RA07X
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 520.763C
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6390
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
C75216
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
10578
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
228275
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
SUB06331MIG
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
100000081838
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
208-186-7
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
8OEC3RA07X
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
768
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
514-73-8
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
CHEMBL1185568
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
221154
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
Dithiazanine iodide
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
m4682
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | Merck Index | ||
|
DBSALT001680
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY | |||
|
DTXSID8022955
Created by
admin on Wed Apr 02 08:31:47 GMT 2025 , Edited by admin on Wed Apr 02 08:31:47 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |